NBSE

NeuBase Therapeutics, Inc. Common Stock
NBSE

Overview Fund Activity
Delisted

NBSE was delisted on the 10th of May, 2024.

Back to rankings

52 hedge funds and large institutions have $22.9M invested in NeuBase Therapeutics, Inc. Common Stock in 2015 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 13 increasing their positions, 15 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
52
Holders Change
+5
Holders Change %
+10.64%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
13
Reduced
15
Closed
6
Calls
$3.27M
Puts
$1.57M
Net Calls
+$1.7M
Net Calls Change
+$2.71M

Top Buyers

1
Deutsche Bank
1
Deutsche Bank
Germany
$1.16M
2
ARTA
2
A.R.T. Advisors
New York
$851K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$4.92M
4
BIT
4
BlackRock Institutional Trust
California
$2.77M
5
Neuberger Berman Group
5
Neuberger Berman Group
New York
$284K

Top Sellers

1
Susquehanna International Group
1
Susquehanna International Group
Pennsylvania
$622K
2
Citadel Advisors
2
Citadel Advisors
Florida
$28K
3
FNBT
3
FineMark National Bank & Trust
Florida
$139K
4
Group One Trading
4
Group One Trading
Illinois
$0
5
BHA
5
Beech Hill Advisors
New York
$104K
Name Holding Trade Value Shares
Change 		Shares
Change %
IA
51
IFP Advisors
Florida
$5K +$5K +2 New
Wells Fargo
52
Wells Fargo
California
$2K -$8K -4 -80%
Citigroup
53
Citigroup
New York
$1K -$4K -4 Closed
Group One Trading
54
Group One Trading
Illinois
– -$167K -151 Closed
Goldman Sachs
55
Goldman Sachs
New York
– -$105K -96 Closed
Millennium Management
56
Millennium Management
New York
– -$66K -60 Closed
PPCM
57
Pillar Pacific Capital Management
California
– -$48K -43 Closed
AIG
58
American International Group
New York
– -$2K -1 Closed
1 2
3